FDA warns of foot, leg amputations with J&J diabetes drug – Reuters
Reuters |
FDA warns of foot, leg amputations with J&J diabetes drug
Reuters Johnson & Johnson (JNJ.N) is required to add new warnings to its diabetes drug, Invokana, about the risk of foot and leg amputations, the U.S. Food and Drug Administration said on Tuesday. Final results from two clinical trials showed leg and foot … FDA Adds Boxed Warning to Canagliflozin for Amputation Risk FDA Issues Safety Alert for Canagliflozin FDA: Boxed Warning for Canagliflozin on Amputation Risk |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.